Table 1.
Baseline characteristics | Group with hypotonic solution n=151 |
Group with isotonic solution n=143 |
P value |
Age in months* | 21, 3–109 | 18, 2–110 | 0.13† |
Age in months* <12 12–24 >24 |
21, 3–109 56 53 45 |
18, 2–110 67 40 38 |
0.13† |
Sex Male |
73 | 59 | 0.22‡ |
Time at study enrolment* | 6±3.2 | 5±2.6 | 0.43† |
Serum sodium concentrations on admission (mEq/L) | 142 (141–145) | 143 (139–146) | 0.75† |
Potassium values (mEq/L) | 4 (3.4–4.4) | 3.9 (3.5–4.8) | 0.71† |
Glucose values in blood (mg/dL) | 121 (109–171) | 134 (110–168) | 0.69† |
Blood pH on admission | 7.41 (7.35–7.45) | 7.402 (7.39–7.51) | 0.67† |
Total volume infused by weight (mL/kg/day) | 69 (45.2–90.3) | 105 (35.8–112.8) | 0.62† |
Diagnosis | Total N=294 |
Group with hypotonic solution n=151 |
Group with isotonic solution n=143 |
P value |
Asthma | 13 | 6 | 7 | 0.11‡ |
Acute respiratory infectious disease | 109 | 53 | 56 | 0.72‡ |
Postbone marrow transplant | 23 | 14 | 11 | 0.66‡ |
Postsurgical | ||||
Neurosurgical | 21 | 10 | 11 | 0.78‡ |
Thoracic | 25 | 11 | 14 | 0.26‡ |
Abdominal | 34 | 19 | 12 | 0.77‡ |
Oncological chemotherapy plan | 37 | 23 | 13 | 0.54‡ |
Seizure disorder | 32 | 15 | 19 | 0.86‡ |
*Median, IQR (25–75).
†Wilcoxon test.
‡Pearson’s χ2 test.